AML Clinical Trials in Aurora, Colorado

4 studies are recruiting for aml in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

    This is a multicenter, genetically-randomized, controlled, Phase 3 study evaluating the efficacy and safety of T-cell receptor-engineered donor T cells targeting HA-2 (TSC-101) administered following reduced-intensity conditioning (RIC) hematopoietic cell transplantation (HCT) in participants with …

    Stage
    Phase 3
    Ages
    18 and older
    Site
    University of Colorado - Anschutz Cancer Center, Aurora, Colorado
    Locations
    26 in total
    Run by
    TScan Therapeutics, Inc.

    See if you can join NCT07702578 on ClinicalTrials.gov

  2. A Phase 1/3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation

    This is a multi-center, non-randomized, concurrent controlled, multi-arm, Phase 1 interventional, open-label, biologic assignment-based umbrella study evaluating the feasibility, safety and preliminary efficacy of an escalating dose regimen of up to 2 doses of TSC-100 and TSC-101 in patients with A…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    University of Colorado - Anschutz Cancer Center, Aurora, Colorado
    Locations
    21 in total
    Run by
    TScan Therapeutics, Inc.

    See if you can join NCT05473910 on ClinicalTrials.gov

  3. Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

    The use of venetoclax-based therapies for pediatric patients with relapsed or refractory malignancies is increasingly common outside of the clinical trial setting. For patients who cannot swallow tablets, it is common to crush the tablets and dissolve them in liquid to create a solution. However, n…

    Stage
    Not phased
    Ages
    0 to 38
    Site
    Children's Hospital Colorado, Aurora, Colorado
    Locations
    5 in total
    Run by
    Children's Hospital Medical Center, Cincinnati

    See if you can join NCT06131801 on ClinicalTrials.gov

  4. CC-486 and Venetoclax for Acute Myeloid Leukemia

    This is an open label, dose escalation Phase I single institution pilot study for relapsed and refractory AML patients using CC-486 (oral azacitidine) with venetoclax. At the completion of dose escalation and after establishment of the MTD or recommended dose of CC-486 with venetoclax, an expansion…

    Stage
    Phase 1
    Ages
    18 to 100
    Site
    CU Anschutz Medical Campus, Aurora, Colorado
    Locations
    2 in total
    Run by
    University of Colorado, Denver

    See if you can join NCT05287568 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.